Nykode collaborates with Roche for an upcoming trial in cervical cancer

Nykode Therapeutics has teamed up with Roche to collaborate in an upcoming clinical trial in advanced cervical cancer.

The trial will investigate Nykode’s lead candidate VB10.16 in combination with Roche’s immunotherapy Tecentriq (atezolizumab).